Cargando…

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders

Antiretroviral therapy has dramatically improved the lives of human immunodeficiency virus 1 (HIV-1) infected individuals. Nonetheless, HIV-associated neurocognitive disorders (HAND), which range from undetectable neurocognitive impairments to severe dementia, still affect approximately 50% of the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mediouni, Sonia, Garibaldi Marcondes, Maria Cecilia, Miller, Courtney, McLaughlin, Jay P., Valente, Susana T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615951/ https://www.ncbi.nlm.nih.gov/pubmed/26557111 http://dx.doi.org/10.3389/fmicb.2015.01164

Ejemplares similares

Systems Biology Analysis of the Antagonizing Effects of HIV-1 Tat Expression in the Brain over Transcriptional Changes Caused by Methamphetamine Sensitization
por: Basova, Liana V., et al.
Publicado: (2020)

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

Molecular Modeling of Subtype-Specific Tat Protein Signatures to Predict Tat-TAR Interactions That May Be Involved in HIV-Associated Neurocognitive Disorders
por: Williams, Monray E., et al.
Publicado: (2022)

Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure
por: Tjitro, Ryan, et al.
Publicado: (2019)

Methamphetamine signals transcription of IL1β and TNFα in a reactive oxygen species-dependent manner and interacts with HIV-1 Tat to decrease antioxidant defense mechanisms
por: Basova, Liana V., et al.
Publicado: (2022)

HIV-1 Tat and cocaine impact mitochondrial epigenetics: effects on DNA methylation
por: Doke, Mayur, et al.
Publicado: (2020)

Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis
por: Dong, Huaqian, et al.
Publicado: (2019)

HIV-1 Tat alters neuronal intrinsic excitability
por: Francesconi, Walter, et al.
Publicado: (2018)

Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system
por: Bortell, Nikki, et al.
Publicado: (2015)

Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription
por: Mousseau, Guillaume, et al.
Publicado: (2019)

Corrigendum: Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis
por: Dong, Huaqian, et al.
Publicado: (2022)

HIV-1 Tat Length: Comparative and Functional Considerations
por: Mele, Anthony R., et al.
Publicado: (2020)

HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models of HIV-associated neurocognitive disorder
por: Ye, Xiang, et al.
Publicado: (2017)

Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS
por: Dahal, Santosh, et al.
Publicado: (2015)

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads
por: Borgmann, Kathleen, et al.
Publicado: (2015)

Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis
por: Basova, Liana, et al.
Publicado: (2021)

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
por: Mousseau, Guillaume, et al.
Publicado: (2012)

Methamphetamine augments HIV-1 gp120 inhibition of synaptic transmission and plasticity in rat hippocampal slices: Implications for methamphetamine exacerbation of HIV-associated neurocognitive disorders
por: Zheng, Ya, et al.
Publicado: (2022)

Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders
por: Fattakhov, Nikolai, et al.
Publicado: (2021)

HIV-associated neurocognitive disorders
por: Sanmarti, Montserrat, et al.
Publicado: (2014)

Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors
por: Mediouni, Sonia, et al.
Publicado: (2022)

Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
por: Kurapati, Kesava Rao V., et al.
Publicado: (2016)

HIV-1 Tat: Role in Bystander Toxicity
por: Ajasin, David, et al.
Publicado: (2020)

Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
por: Mediouni, Sonia, et al.
Publicado: (2019)

Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive Disorders
por: Gurwitz, Kim T., et al.
Publicado: (2017)

Novel RNA-Seq Signatures Post-Methamphetamine and Oxycodone Use in a Model of HIV-Associated Neurocognitive Disorders
por: Athota, Pranavi, et al.
Publicado: (2023)

In vivo effects of methamphetamine on brown fat reactive oxygen species and mitochondria
por: Bortell, Nikki, et al.
Publicado: (2015)

HIV Associated Neurocognitive Disorders
por: Zhou, Li, et al.
Publicado: (2013)

Reply to Augello, P.A.; Wu, J. Comment on “Rogers et al. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. Viruses 2023, 15, 674”
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol
por: Bertrand, Sarah J., et al.
Publicado: (2015)

Methamphetamine and Inflammatory Cytokines Increase Neuronal Na(+)/K(+)-ATPase Isoform 3: Relevance for HIV Associated Neurocognitive Disorders
por: Pendyala, Gurudutt, et al.
Publicado: (2012)

HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: microglia-neuron cross-talk in NeuroHIV
por: Kannan, Muthukumar, et al.
Publicado: (2022)

Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection
por: Basova, Liana, et al.
Publicado: (2018)

Potent suppression of HIV viral replication by a novel inhibitor of Tat
por: Mousseau, Guillaume, et al.
Publicado: (2012)

Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
por: Li, Chuan, et al.
Publicado: (2019)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
por: Maubert, Monique E., et al.
Publicado: (2016)

Impact of Genetic Variations in HIV-1 Tat on LTR-Mediated Transcription via TAR RNA Interaction
por: Ronsard, Larance, et al.
Publicado: (2017)

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
por: Mousseau, Guillaume, et al.
Publicado: (2015)

MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
por: Basova, Liana V., et al.
Publicado: (2023)

Neuroimaging of HIV-associated neurocognitive disorders
por: Haziot, Michel Elyas Jung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qvufq2c5jj5tvuucvjifi0oeu9